Loading organizations...
Loading organizations...
Boom Capital Ventures: Venture capital firm investing in early-stage deep tech startups focused on science frontiers, including biotech, AI, and aerospace.
Key people at Boom Capital Ventures.
Boom Capital Ventures is a San Francisco, California-based venture capital firm that invests in early-stage, deeply technical founders building at the frontiers of science and deep tech. The firm primarily targets pre-seed and seed funding rounds across complex sectors such as healthcare, genomics, machine intelligence, aerospace, and new chemistries. Operating with a highly focused 12-company portfolio, the firm manages multiple investment vehicles, including its inaugural 2018 fund and its third fund which officially opened for fundraising in July 2025. Boom Capital Ventures has backed several notable deep science startups, including Mammoth Biosciences, Fauna Bio, Bioloomics, Endpoint Health, and Harmonic Discovery. The firm remains actively engaged in deploying capital to under-networked scientists, having already executed two new investments during the first quarter of 2025. Boom Capital Ventures was founded in 2017 by Celestine Schnugg.
Key people at Boom Capital Ventures.
Boom Capital Ventures is a venture capital firm dedicated to empowering deeply technical, under-networked founders who are building transformative companies at the frontiers of science. The firm’s mission centers on identifying and supporting “scientist-protagonists”—visionary founders working in areas like healthcare, genomics, machine intelligence, aerospace, and new chemistries. Boom Capital’s investment philosophy is rooted in early-stage, hands-on partnership, often engaging with founders before broader market validation. By providing capital, strategic guidance, and access to a robust network, Boom Capital accelerates the growth of startups poised to reshape their industries. Their impact is evident in a portfolio that includes notable names such as Mammoth Biosciences, Fauna Bio, and Diligent Robotics, all of which are pushing the boundaries of scientific innovation.
Founded in 2016 (with incorporation in 2017), Boom Capital Ventures emerged from a recognition that many of the most impactful scientific breakthroughs are driven by founders who are brilliant but often lack access to traditional venture networks. The firm was established in San Francisco, California, and quickly positioned itself as a champion for pre-seed and early-stage ventures in deep technology. The founding partners brought extensive experience in venture capital and a data-driven, operator-first approach, having executed over 50 deals across technology, healthcare, and renewable energy. Over time, Boom Capital has evolved its focus to concentrate on the most cutting-edge scientific sectors, building a reputation for spotting high-potential founders before they become mainstream darlings.
Boom Capital Ventures is riding the wave of a new era in scientific entrepreneurship, where breakthroughs in genomics, AI, and advanced materials are increasingly driven by small, agile teams rather than large corporations. The timing is critical: as the cost of scientific experimentation drops and the pace of innovation accelerates, early-stage investors like Boom Capital are uniquely positioned to identify and nurture the next generation of transformative companies. Their focus on under-networked founders also addresses a key gap in the startup ecosystem, democratizing access to capital and expertise for scientists who might otherwise struggle to commercialize their ideas. By doing so, Boom Capital is helping to shape a future where scientific innovation is more inclusive and impactful.
Boom Capital Ventures is poised to remain a key player in the deep tech and life sciences investment landscape, as the demand for scientific innovation continues to grow. The firm’s ability to spot and support visionary founders early will likely yield more high-profile exits and breakthrough companies in the coming years. Trends such as the convergence of AI and biology, the rise of synthetic biology, and the increasing importance of climate tech will further amplify Boom Capital’s influence. As the scientific startup ecosystem matures, Boom Capital’s model of hands-on, early-stage partnership may become a blueprint for other investors seeking to drive meaningful progress at the intersection of science and technology. Their journey is a testament to the power of backing the right people at the right time—scientist-protagonists who are building the future.
